Raft Of Chinese Pharmas Join Active Financing Market

December has been a busy financing month for the pharmaceutical industry in China, the key takeaways from the hectic activity being a series of major fundraisings and a trend for pharma companies from mainland China to tap into the active Hong Kong stock market through IPOs.